Login

Mike Speetzen, CEO of Polaris, joins 'Closing Bell: Overtime' to discuss investor day, earnings, and the state of the high-ticket consumer market. 00:10:00

Share On Facebook Share On Twitter

Marc Murnaghan - Polaris Renewable Energy Inc.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Expansion and Growth: Bass Metals' Strategic Overview and Future Prospects
00:10:00
Journey to Sustainability: Transforming Waste into Opportunity | Milton Pilão Júnior, CEO, Orizon Valorizacao.
00:10:00
ASX-listed Sipa Resources Eyes New Partnerships to Advance Promising Nickel-Copper Project in Uganda
00:10:00
Gain valuable insights into the strategic initiatives, innovative projects, and future prospects of Hecla Mining Company|Phillips S. Baker, Jr,President and CEO of Hecla Mining Company
00:10:00
Highlights from Belimo CEO Lars van der Haegen's 2015 Platinum Meeting: Exciting Product Teasers for 2016 | Lars van der Haegen - CEO of Belimo Holding AG
00:10:00
WATCH: #BCDA President and CEO Vince Dizon discusses developments at Metro Pacific Investments Corporation.
00:10:00
All Circor employees get stake in company | Tony Najjar, CEO, Circor International IncCIR:NYQ
00:10:00
The Executive Director of The Naga Group AG discusses Cyprus as an ideal business location for ICT companies at the Invest Cyprus Roadshow (The Americas).
00:10:00
Capral Limited at the ASX Small and Mid-Cap Conference with Proactive | MR TONY DRAGICEVICH., CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR, CAPRAL LTD
00:10:00
Emerging Trends in Global Finance: A Discussion with Leaders in Private Equity and Market Strategy | Frank Tang, CEO, FountainVest Partners.
00:10:00
Exploring the Future of Smart Cities: Interview with Rob Mostert at the ICANN Conference in Madrid
00:00:00
C4X Discovery Holdings PLC bags a billion molecules -Clive Dix BSc PhD HonFBPhS, Interim Executive Chairman & CEO, C4X Discovery Holding

© 2026 Nehu